Zocon DT is used to treat serious fungal or yeast infections, such as vaginal candidiasis, oropharyngeal candidiasis (thrush, oral thrush), esophageal candidiasis (candida esophagitis), other candida infections (including urinary tract infections, peritonitis [inflammation of the lining of the abdomen or stomach], and infections that may occur in different parts of the body), or fungal (cryptococcal) meningitis. Zocon DT works by killing the fungus or yeast, or preventing its growth. Zocon DT Injection is also used to prevent candidiasis in patients having bone marrow transplants, who receive cancer or radiation treatment. Zocon DT is to be given only by or under the direct supervision of a doctor.

Although there are rare cases of adverse hepatic effects during Zocon-50 DT Tablet 4's treatment, it is advisable to check on possibilities. Severe hepatic reactions like necrosis (death of cells or tissue), clinical hepatitis (inflammation of the liver), cholestasis (reduction or blockage of bile from the liver), and sudden hepatic failure are reported during Zocon-50 DT Tablet 4's therapy. Zocon-50 DT Tablet 4's is associated with liver toxicity, including fatalities in patients with other serious underlying diseases. Treatment with Zocon-50 DT Tablet 4's should be immediately discontinued in such cases. Zocon-50 DT Tablet 4's may also cause heart problems (like irregular heart rhythm), so it should be used with caution in patients with heart diseases. Pregnant or lactating women should consult the doctor before taking this drug. Zocon-50 DT Tablet 4's may not be suitable for some people who have weakened immune system, diabetes, cancer, or low blood magnesium or potassium levels.